CClinicalTrials.gg
RecruitingNCT06148324Updated Jan 28, 2026

MENTOR Wellness Program

An interventional study of MENTOR Program in Traumatic Brain Injury, sponsored by NYU Langone Health. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-01-28.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This randomized trial aims to determine the effectiveness a virtual wellness intervention program in individuals with traumatic brain injury (TBI). Participants will be randomized at enrollment into two groups: immediate treatment (IT) and delayed treatment (DT) group. This study will also provide insights into the impact of these intervention's components in helping emotional, physical, and nutritional outcomes post-injury in the context of social determinants of health (SDOH).

02

Conditions studied

  • Traumatic Brain Injury

Keywords

  • traumatic brain injury
  • TBI
  • brain injury
  • wellness
  • physical activity
  • nutrition
  • chronic
  • mindfulness
03

In context

Brain Injuries, Traumatic

1,775 studies on the registry are indexed under Brain Injuries, Traumatic; 448 are open to participants now.

This study's planned enrollment of 138 is above the median of 56 across 1,133 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.

Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Have a medically-documented (e.g., EMS report, hospital record, physician record) or per medical monitor review complicated-mild, moderate, or severe TBI requiring admission to an acute inpatient rehabilitation unit
  • Be at least 12 months post-TBI
  • Have access to the internet on a computer, tablet, and/or smartphone.
  • Speak and understand English or Spanish
  • Agree to participate
  • Are medically cleared by their primary physician, physiatrist, neurologist, rehabilitation therapist, or other recognized health professional to participate in the study

Exclusion criteria

Exclusion Criteria:

  • No history of complicated-mild, moderate, or severe TBI
  • Less than 12 months post-TBI
  • In minimally conscious or vegetative state
  • Beginning a new treatment regimen (e.g., physical therapy, occupational therapy, vestibular therapy, psychotherapy, and/or medication) at study start that can influence study findings in the judgment of the principal investigator and/or medical monitor (participants whose treatment regimens are stable will be eligible)
  • In the judgment of the principal investigator, medical monitor, and/or study team member, presence of significant cognitive impairment (i.e. delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection
  • In the judgment of the principal investigator, medical monitor, and/or study team member, significant or major disabling medical condition sufficient to preclude meaningful informed consent and/or data collection
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
138 participants (estimated)

Study arms

  • Experimental
    Immediate treatment (IT)

    Participants randomized to the IT arm will receive the 8-week MENTOR program, followed by an 8-week retention period.

    Behavioral: MENTOR Program

  • Experimental
    Delayed treatment (DT)

    Participants randomized to the DT arm will have an 8-week waitlist period prior to starting the 8-week MENTOR program, followed by an 8-week retention period.

    Behavioral: MENTOR Program

Interventions

  • BehavioralMENTOR Program

    MENTOR is an online wellness program covering 11 wellness modules: Exercise; Nutrition; Mindfulness; Spiritual Practice; Self-Care; Arts \& Leisure; Rest \& Relaxation; Outdoors in Nature; Relationships; Core Values; and Contribution to Others. The 8-week cycle comprises 40 hours of online group-based instruction and discussion, meeting up to five times per week.

06

What researchers measure

Primary outcomes

  1. Freiburg Mindfulness Inventory (FMI) Score at Baseline

    14-item scale measuring mindfulness. Items are rated on a scale from 1 (rarely) to 4 (almost always); the total score is the sum of responses and ranges from 14 to 56; higher scores indicate greater levels of mindfulness.

    Time frame: Baseline

  2. Freiburg Mindfulness Inventory (FMI) Score at Post-Intervention Assessment

    14-item scale measuring mindfulness. Items are rated on a scale from 1 (rarely) to 4 (almost always); the total score is the sum of responses and ranges from 14 to 56; higher scores indicate greater levels of mindfulness.

    Time frame: Post-Intervention Assessment (Week 8 for IT; Week 16 for DT)

  3. International Physical Activity Questionnaire (IPAQ) Score at Baseline

    The IPAQ calculates the metabolic equivalent (MET) score by asking participants the days and minutes exercised in three categories of intensity (vigorous, moderate, and walking) during the previous one week. The following formula is used to calculate the MET: MET=8(vigorous activity) (minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes).

    Time frame: Baseline

  4. International Physical Activity Questionnaire Score at Post-Intervention Assessment

    The IPAQ calculates the metabolic equivalent (MET) score by asking participants the days and minutes exercised in three categories of intensity (vigorous, moderate, and walking) during the previous one week. The following formula is used to calculate the MET: MET=8(vigorous activity) (minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes).

    Time frame: Post-Intervention Assessment (Week 8 for IT; Week 16 for DT)

  5. Health Promoting Lifestyle Profile II (HPLP-II) Score at Baseline

    53-item self-assessment of nutritional and health-related habits. Items are rated on a scale from 1 (never) to 4 (routinely); the total score is the sum of responses and ranges from 52 to 208. Higher scores indicate nutritional and health-related habits that are more closely associated with good health outcomes.

    Time frame: Baseline

  6. Health Promoting Lifestyle Profile II (HPLP-II) Score at Post-Intervention Assessment

    53-item self-assessment of nutritional and health-related habits. Items are rated on a scale from 1 (never) to 4 (routinely); the total score is the sum of responses and ranges from 52 to 208. Higher scores indicate nutritional and health-related habits that are more closely associated with good health outcomes.

    Time frame: Post-Intervention Assessment (Week 8 for IT; Week 16 for DT)

  7. Connor-Davidson Resilience Scale 10 (CD-RISC-10) Score at Baseline

    10-item assessment of how participants feel when faced with various difficult situations. Each item is rated on a scale from 0 (not true at all) to (true nearly all the time). The total score is the sum of responses and ranges from 0 to 40; higher scores indicate greater resilience.

    Time frame: Baseline

  8. Connor-Davidson Resilience Scale 10 (CD-RISC-10) Score at Post-Retention Assessment

    10-item assessment of how participants feel when faced with various difficult situations. Each item is rated on a scale from 0 (not true at all) to (true nearly all the time). The total score is the sum of responses and ranges from 0 to 40; higher scores indicate greater resilience.

    Time frame: Post-Retention Period Assessment (Week 16 for IT; Week 24 for DT)

  9. Perceived Stress Scale (PSS) Score at Baseline

    10-item assessment of perceived stress. Each item is rated on a scale from 0 (never) to 4 (very often). The total score is the sum of responses and ranges from 0 to 40; higher scores indicate higher perceived stress.

    Time frame: Baseline

  10. Perceived Stress Scale (PSS) Score at Post-Retention Assessment

    10-item assessment of perceived stress. Each item is rated on a scale from 0 (never) to 4 (very often). The total score is the sum of responses and ranges from 0 to 40; higher scores indicate higher perceived stress.

    Time frame: Post-Retention Period Assessment (Week 16 for IT; Week 24 for DT)

  11. Participation Assessment with Recombined Tools - Objective (PART-O) Score at Baseline

    10-item assessment of participation in the community. Each item is rated on a scale from 0-5; the total score is the sum of responses and ranges from 0 to 50; higher scores indicate greater community participation.

    Time frame: Baseline

  12. Participation Assessment with Recombined Tools - Objective (PART-O) Score at Post-Retention Assessment

    10-item assessment of participation in the community. Each item is rated on a scale from 0-5; the total score is the sum of responses and ranges from 0 to 50; higher scores indicate greater community participation.

    Time frame: Post-Retention Period Assessment (Week 16 for IT; Week 24 for DT)

  13. Quality of Life after Brain Injury (QOLIBRI) Score at Baseline

    37-item assessment of quality of life following brain injury. Items rated on a scale from 1 (not at all) to 5 (very). The total score is the sum of responses and ranges from 37 to 185; higher scores indicate greater quality of life.

    Time frame: Baseline

  14. Quality of Life after Brain Injury (QOLIBRI) Score at Post-Retention Assessment

    37-item assessment of quality of life following brain injury. Items rated on a scale from 1 (not at all) to 5 (very). The total score is the sum of responses and ranges from 37 to 185; higher scores indicate greater quality of life.

    Time frame: Post-Retention Period Assessment (Week 16 for IT; Week 24 for DT)

  15. 12-Item Short Form Survey (SF-12) Score at Baseline

    12-item assessment of general health. The raw score is the sum of responses; the raw score is transformed to a summary t-score with a mean of 50 and standard deviation of 10; higher scores indicate greater overall health.

    Time frame: Baseline

  16. 12-Item Short Form Survey (SF-12) Score at Post-Retention Assessment

    12-item assessment of general health. The raw score is the sum of responses; the raw score is transformed to a summary t-score with a mean of 50 and standard deviation of 10; higher scores indicate greater overall health.

    Time frame: Post-Retention Period Assessment (Week 16 for IT; Week 24 for DT)

  17. WHO-Quality of Life - Spirituality, Religious and Personal Beliefs module (WHOQOL-SRPB BREF) Score at Baseline

    32-item assessment of how beliefs have affected different aspects of a participant's quality of life over the past two weeks. Items are rated on a scale from 1 (not at all) to 5 (an extreme amount). The total score is the sum of responses and ranges from 32 to 160; higher scores indicate beliefs have a greater impact on the participant's quality of life.

    Time frame: Baseline

  18. WHO-Quality of Life - Spirituality, Religious and Personal Beliefs module (WHOQOL-SRPB BREF) Score at Post-Retention Assessment

    32-item assessment of how beliefs have affected different aspects of a participant's quality of life over the past two weeks. Items are rated on a scale from 1 (not at all) to 5 (an extreme amount). The total score is the sum of responses and ranges from 32 to 160; higher scores indicate beliefs have a greater impact on the participant's quality of life.

    Time frame: Post-Retention Period Assessment (Week 16 for IT; Week 24 for DT)

  19. Flourishing Scale Score at Baseline

    8-item assessment of general prosperity. Each item is rated on a scale from 1 (strongly disagree) to 7 (strongly agree). The total score is the sum of responses and ranges from 8-56; higher scores indicate greater prosperity.

    Time frame: Baseline

  20. Flourishing Scale Score at Post-Retention Assessment

    8-item assessment of general prosperity. Each item is rated on a scale from 1 (strongly disagree) to 7 (strongly agree). The total score is the sum of responses and ranges from 8-56; higher scores indicate greater prosperity.

    Time frame: Post-Retention Period Assessment (Week 16 for IT; Week 24 for DT)

07

Study locations

1 of 1 sites recruiting
  • NYU Langone Health
    New York, New York 10016, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The de-identified participant data from the final research dataset used in the published manuscript will be shared with researchers who provide a methodologically sound proposal to achieve aims in the approved protocol. The request may be submitted beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the researchers execute a data use agreement with NYU Langone Health. Requests may be directed to: Tamara.Bushnik@nyulangone.org. After 36 months, the data will be available in NYU Langone's data warehouse but without investigator support other than deposited metadata. Information regarding submitting requests and accessing data may be found at ICPSR Data Excellence Research Impact (umich.edu). The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06148324
Lead sponsor
NYU Langone Health
Collaborators
National Institute on Disability, Independent Living, and Rehabilitation Research, University of Alabama at Birmingham
Responsible party
Sponsor
First posted
Nov 28, 2023
Start date
Apr 11, 2024
Primary completion
Mar 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Jan 28, 2026

Study contacts

Fatima Imdad
Contact
Fatima.Imdad@nyulangone.org
917-376-2270
Michelle Michelle.Smith@nyulangone.org
Contact
Michelle.Smith@nyulangone.org
646-501-9162
Tamara Bushnik, PhD
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion